HIV/AIDS/STIs and TB (HAST) Research Programme, Human Sciences Research Council, Pretoria, South Africa.
Department of Research & Innovation, University of Limpopo, Sovenga, South Africa.
Arch Womens Ment Health. 2020 Feb;23(1):101-111. doi: 10.1007/s00737-019-00955-7. Epub 2019 Feb 23.
This study investigated perinatal depressive symptoms among HIV-infected women enrolled in a cluster-randomized, controlled trial in South Africa. Women (n = 1370) attending 12 community health centers were consecutively enrolled in a two-phase (phase 1 = without a male partner, phase 2 = with a male partner) and two-condition (experimental or control) prevention of mother-to-child transmission (PMTCT) intervention. Women were enrolled at 8-24 weeks pregnant and followed postpartum at 6 weeks and 6 and 12 months (retention rate = 69.8%). Antenatally, 45.4% of women were above the 12-point Edinburgh Postnatal Depression Scale (EPDS) cutoff, 30.2% were above the cutoff at 6 weeks, and 34.2% and 36.9% at 6 months and 12 months postpartum, respectively. In multilevel regression analyses, depressive symptoms decreased over time among women in phase 2 participating in the intervention condition, but neither condition nor phase alone was associated with a decrease in depression. Greater HIV stigma, increased psychological intimate partner violence, less male involvement, lower education, and non-adherence during pregnancy were associated with increased depressive symptoms over the perinatal period. Results indicated that women participating had high levels of depressive symptoms (> 40% prenatally and > 30% postnatally), and the combination of the multi-session PMTCT intervention plus male partner participation contributed to a reduction in depressive symptoms. Results suggest that interventions targeting the reduction of depressive symptoms in perinatal HIV-positive women by increasing male involvement and decreasing HIV stigma and intimate partner violence are needed to reduce depression in this vulnerable population.
本研究调查了在南非进行的一项集群随机对照试验中感染 HIV 的女性的围产期抑郁症状。在 12 个社区卫生中心连续招募了 1370 名女性,她们分两阶段(阶段 1:没有男性伴侣;阶段 2:有男性伴侣)和两条件(实验组或对照组)参与预防母婴传播(PMTCT)干预。女性在怀孕 8-24 周时入组,并在产后 6 周、6 个月和 12 个月时进行随访(保留率为 69.8%)。产前,45.4%的女性的爱丁堡产后抑郁量表(EPDS)得分超过 12 分,30.2%在产后 6 周时得分超过 12 分,分别有 34.2%和 36.9%在产后 6 个月和 12 个月时得分超过 12 分。在多水平回归分析中,参与干预组的第二阶段的女性抑郁症状随时间逐渐减轻,但条件或阶段本身均与抑郁减轻无关。HIV 耻辱感增加、心理亲密伴侣暴力增加、男性参与度降低、教育程度较低和孕期不依从与围产期抑郁症状增加有关。结果表明,参与研究的女性有较高的抑郁症状水平(产前>40%,产后>30%),多疗程 PMTCT 干预加上男性伴侣参与有助于减轻抑郁症状。结果表明,需要针对增加男性参与度、减少 HIV 耻辱感和亲密伴侣暴力来减少围产期 HIV 阳性女性抑郁症状的干预措施,以降低这一脆弱人群的抑郁水平。